The team at PharmaWatch is continuously innovating to provide the best available solution to meet our client’s monitoring needs. By ensuring that the stored goods are monitored properly we are confident that the recipient of the vaccine, tissue or other stored material is receiving those goods that will meet the manufacturer’s specifications and remain viable.
When utilizing the PharmaWatch real-time monitoring solution, our clients are assured of the integrity of the goods. We, at PharmaWatch, feel we serve society as well, by meeting at the intersection of the Pharma client and the end recipient.
As stated on the CDC Website, “CDC has developed a new laboratory test kit for use in testing patient specimens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19.” Critical to the proper administration and accurate test result is the proper storage and handling of the test kits. The Center for Disease Control and Prevention (CDC) specifies that the test kits be stored at 2 to 8°C (36 to 46°F). The guidance further notes when shipping the test kits and samples should be on an ice pack.
Monitoring the cold storage unit or transport package with the PharmaWatch solution will help ensure the integrity of the kit and the test results. We at PharmaWatch are doing our utmost to ensure the inventory monitored by our solution is maintained to the highest level of quality.
